Flu new drug approved only 1 year, Shi Yao Ou Yi that is the first copy! Roche responds... 2022-10-20
A quarter of a billion dollars! Merck Partners with Moderna to Advance mRNA cancer Vaccine plus K drug for melanoma 2022-10-20
Sodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapySodium thiosulfate has been approved by the FDA to reduce hearing loss in children caused by chemotherapy 2022-10-20
When is "water inverse" going on? Biogens ALS drug approval delayed to next April 2022-10-20
Not as good as a placebo? Relmada Therapeutics Shares plunge 80% after Phase 3 trial of New Drug for Major Depression fails! 2022-10-20
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time? 2022-10-18
From the long-term insulin Icodec phase III study GrSlam, looking at the development history of Novo Nordisk 2022-10-18
With a second drug in Phase III for Alzheimers, Can Bonjian turn the tide this time? 2022-10-18
Semaglutide: Another phenomenon-level new drug, breaking one billion in "seconds", the "weight loss" market is basically out of stock 2022-10-14
Preliminary clinical success of Pfizers oral GLP-1 agonist 2022-09-30
New study shows that daily multivitamins may ameliorate Alzheimers disease 2022-09-30
Market Report of Monoclonal Antibody Drugs in China (2022) 2022-09-20
Chinas National Health Insurance Bureau is studying the inclusion of innovative medical supplies into medical insurance 2022-08-31
FDA approves ibrutinib for chronic graft-versus-host disease in children 1 year older 2022-08-31
First BCMA/CD3 dual antibodies approved by EU 2022-08-31
FDA Approves Bluebird Gene Therapy Zynteglo 2022-08-23
CXO -- Booming industry strong demfor R&D 2022-08-23
Pharmaceutical Equipment - Continued prosperous development, biologics market expansion brings important drivers 2022-08-23
Vaccines - COVID-19 epidemic drives rapid industry development 2022-08-23
Life science reagents - Strong demfor research development, industry favorable policies continue 2022-08-23
FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detected Potential Carcinogen 2022-08-17
Breaking News! Chinas First KRAS G12D Inhibitor Approved for Clinical Use 2022-08-15
Pfizers $11.6 Billion Double-acting Migraine Drug Generates $318 Million in First-half Revenue 2022-08-09
2022H1: Top 10 Best-Selling Drugs in the World 2022-08-08
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing 2022-08-03
Upadatinibs launch accelerated: Crohns disease has simultaneously submitted marketing applications in FDA&EMA 2022-08-02
Huadong Medicine Liraglutide Injection for Obesity or Overweight Indication Application for Listing 2022-08-02
AbbVie Ends An Alzheimers Immunotherapy Collaboration with Alector 2022-07-13
Oseltamivir is Gone, the Pattern of Anti-influenza Drugs is Reversed! 2022-06-26
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib 2022-06-26
Phase III Study of AstraZenecas Innovative Therapy was Successful! A Listing Application Will be Submitted 2022-06-26
AstraZeneca/Mersk & Co.s MEK Inhibitor Filed for Listing in China 2022-06-14
共
1472 个 页次:
3 /
46 页
32 个/页
首页 上一页 下一页 尾页
转到：
第1页
第2页
第3页
第4页
第5页
第6页
第7页
第8页
第9页
第10页
第11页
第12页
第13页
第14页
第15页
第16页
第17页
第18页
第19页
第20页
第21页
第22页
第23页
第24页
第25页
第26页
第27页
第28页
第29页
第30页
第31页
第32页
第33页
第34页
第35页
第36页
第37页
第38页
第39页
第40页
第41页
第42页
第43页
第44页
第45页
第46页
Our Advantages of Reports
①All reports written by ourselves
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
News 
